TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Updated ACC/AHA guidance published in March 2026 gives coronary artery calcium scans a central role for some adults whose need for preventive treatment is uncertain. The scan can help identify calcified plaque, but the opinion article argues that insurance coverage and routine use have not kept pace; broad coverage and outcomes from expanded use remain unclear.
The American College of Cardiology and American Heart Association gave coronary artery calcium scans a more central role in their March 2026 prevention guidelines, recommending the test for some adults with borderline or intermediate coronary risk when clinicians and patients remain uncertain about preventive treatment. The change addresses a gap highlighted by two physician authors: a relatively low-cost scan can detect calcified plaque, but its availability and payment have not necessarily matched its role in guidance.
A coronary artery calcium (CAC) scan is a brief imaging test that detects calcified plaque in the arteries supplying the heart. In an opinion article published by MedPage Today on October 25, 2026, cardiologists Arthur Agatston and Oren Mechanic describe the scan as taking about 10 minutes and costing around $100. That price is the authors’ estimate; the amount a patient pays can vary, and the article does not provide a national coverage or pricing analysis.
The guideline recommendation is targeted, not a universal screening directive. According to the authors’ account, CAC scanning can help when an adult’s estimated risk is borderline or intermediate and the decision to begin a preventive therapy, such as a statin, is unsettled. Risk calculators estimate the likelihood of an event using factors including age, cholesterol, blood pressure, diabetes and smoking. A scan instead looks for calcified atherosclerotic plaque, which can change a clinician’s assessment of risk.
The authors illustrate the distinction with a patient whose name they changed. They say the 52-year-old had a CAC score of 220 despite a low-risk estimate from a conventional calculator; they interpret the result as a substantial plaque burden for his age and say it supported treatment. The example is an individual case, not evidence on its own that scanning prevents heart attacks across a population. The article also says a score of zero can lower estimated risk, while a score above 100 may support medication and intensive lifestyle measures.
Guidance Meets Payment and Access
The update matters because it gives clinicians another tool when standard risk estimates do not settle whether preventive treatment is appropriate. Identifying plaque may help inform a discussion about medication and lifestyle changes, while a zero score may affect that discussion in the other direction. The scan does not itself prevent a heart attack, and the guidance described here applies to a defined group rather than everyone.
The article’s central policy argument is that reimbursement and routine practice can shape whether patients receive a recommended test. Agatston and Mechanic say some patients have had to pay out of pocket for CAC scans. They contrast an estimated scan cost of about $100 with a stated $50,000 cost for a heart attack, arguing that payment systems should put more emphasis on prevention. Those figures are the authors’ framing; the article does not specify the source, setting or components behind the heart-attack cost, so they should not be treated as a universal price comparison.
Access is consequential if cost prevents people from discussing or receiving testing that clinicians consider appropriate. At the same time, coverage decisions involve more than comparing a scan’s price with the cost of an emergency. The article does not establish that expanding insurance payment would produce a particular reduction in heart attacks or overall spending. The policy question is how to make evidence-based prevention accessible while using imaging selectively and appropriately.
home blood pressure monitor upper arm
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How CAC Entered Prevention Guidance
For decades, clinicians have commonly used risk calculators based on population-level factors to estimate cardiovascular risk. The authors argue that these tools cannot show whether an individual already has coronary plaque and may not capture every source of risk, including family history and genetic factors. CAC imaging offers a different kind of information by showing calcified plaque, though it is not a complete measure of every form of coronary disease.
The authors say the test had a limited place in national guidance for roughly 35 years before the March 2026 update. The revised recommendation described in the article is for cases where estimated risk leaves a treatment decision uncertain. It does not replace risk assessment, a clinician’s evaluation or discussion of treatment benefits and risks.
Agatston and Mechanic also point to AI analysis of existing chest CT scans as a possible way to identify visible vascular calcification in images taken for other reasons. They say AI tools are being used to measure soft plaque as well as calcification. The article presents this as a developing opportunity, not as a settled replacement for dedicated testing or a confirmed population-wide screening program.
“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”
— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their MedPage Today opinion article
As an affiliate, we earn on qualifying purchases.
Coverage and Outcomes Still Unsettled
The article does not provide a detailed account of how Medicare or private insurers will cover CAC scans under the revised guidelines, what eligibility rules apply, or how often patients currently pay out of pocket. Its headline’s $50,000 and $100 figures are not accompanied by a defined billing dataset or cost comparison, so they should be understood as the authors’ argument rather than a confirmed Medicare payment rate for every heart attack or a universal scan price.
The supplied report also does not include the full guideline text, recommendation grading or evidence tables. It therefore does not establish that every adult at borderline or intermediate risk should be scanned, nor does it quantify how the change will affect heart-attack rates, treatment decisions, harms or total healthcare spending. The claimed potential of AI to identify disease in existing scans also needs to be distinguished from established clinical outcomes and coverage policy.
As an affiliate, we earn on qualifying purchases.
How Clinicians and Payers Respond
The immediate next step is implementation: clinicians and health systems will need to apply the revised recommendation to the patients it describes and discuss whether imaging would help resolve a specific treatment decision. Payer policies and out-of-pocket costs will shape whether patients can access the test; the opinion article does not report a new Medicare coverage decision or a timetable for one.
Further information that would clarify the policy debate includes the full guideline recommendation, insurer coverage rules, actual patient costs and outcome data from use in clinical practice. Any wider use of AI to read existing scans will also depend on how tools are validated and integrated into follow-up care. Until those details emerge, the confirmed development is the guideline change—not a guarantee of coverage or proof that broader scanning will prevent a specified number of heart attacks.
As an affiliate, we earn on qualifying purchases.
Key Questions
What changed in the March 2026 guidelines?
According to the authors’ account, the ACC and AHA gave CAC scanning a central role for adults at borderline or intermediate risk when the decision about preventive therapy remains uncertain. It is not described as a recommendation to scan everyone.
What does a coronary artery calcium scan detect?
A CAC scan detects calcified plaque in the arteries supplying the heart. Clinicians may use the result alongside other risk information when discussing prevention; the scan does not by itself diagnose every form of coronary disease.
Does Medicare now pay for every CAC scan?
The source article does not report a new Medicare coverage rule or confirm that Medicare pays for every scan. Patients should check current coverage and costs with their health plan and clinician.
Does a calcium score of zero mean there is no heart disease?
No such conclusion is established by the source. The authors say a score of zero can reclassify risk downward, but scan results should be interpreted with a clinician and do not replace an overall assessment of health and risk factors.
Is AI analysis of existing CT scans already standard care?
The authors describe AI-based analysis as a developing approach and say it is being used to assess calcification and soft plaque. The article does not establish that this is standard practice or provide evidence of its population-wide outcomes.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
